NeuroMetrix (NASDAQ: NURO)
$4.33
(18.6%)
$0.68
Price as of April 19, 2024, 3:59 p.m. ET
NeuroMetrix Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NeuroMetrix Company Info
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. Its products include DPNCheck, Quell, and ADVANCE system. It also focuses on the sale of medical equipment and consumables. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.